DK123912B - Fremgangsmåde til fremstilling af et granulat, der indeholder et olieagtigt eller flydende, terapeutisk anvendeligt glucofuranosid. - Google Patents

Fremgangsmåde til fremstilling af et granulat, der indeholder et olieagtigt eller flydende, terapeutisk anvendeligt glucofuranosid.

Info

Publication number
DK123912B
DK123912B DK418069AA DK418069A DK123912B DK 123912 B DK123912 B DK 123912B DK 418069A A DK418069A A DK 418069AA DK 418069 A DK418069 A DK 418069A DK 123912 B DK123912 B DK 123912B
Authority
DK
Denmark
Prior art keywords
glucofuranoside
oily
preparation
liquid
therapeutically useful
Prior art date
Application number
DK418069AA
Other languages
Danish (da)
English (en)
Inventor
G Mueller
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK123912B publication Critical patent/DK123912B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK418069AA 1968-08-05 1969-08-04 Fremgangsmåde til fremstilling af et granulat, der indeholder et olieagtigt eller flydende, terapeutisk anvendeligt glucofuranosid. DK123912B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1170468 1968-08-05

Publications (1)

Publication Number Publication Date
DK123912B true DK123912B (da) 1972-08-21

Family

ID=4376070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK418069AA DK123912B (da) 1968-08-05 1969-08-04 Fremgangsmåde til fremstilling af et granulat, der indeholder et olieagtigt eller flydende, terapeutisk anvendeligt glucofuranosid.

Country Status (23)

Country Link
US (2) US3594474A (ro)
AT (1) AT290731B (ro)
BE (1) BE737053A (ro)
BG (1) BG17466A3 (ro)
BR (1) BR6911321D0 (ro)
CA (1) CA938889A (ro)
CY (1) CY790A (ro)
DE (1) DE1938108C3 (ro)
DK (1) DK123912B (ro)
FI (1) FI50058C (ro)
FR (1) FR2015053A1 (ro)
GB (1) GB1259387A (ro)
IE (1) IE33246B1 (ro)
IL (1) IL32673A (ro)
IT (1) IT1035508B (ro)
MY (1) MY7500079A (ro)
NL (1) NL162837C (ro)
NO (1) NO129183B (ro)
OA (1) OA03604A (ro)
PL (1) PL88871B1 (ro)
RO (1) RO57881A (ro)
SE (1) SE363735B (ro)
SU (1) SU409407A3 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
DE3773926D1 (de) * 1987-07-22 1991-11-21 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
AT290731B (de) 1971-06-11
FI50058C (fi) 1975-12-10
DE1938108A1 (de) 1970-02-26
CA938889A (en) 1973-12-25
NL6911864A (ro) 1970-02-09
US3655870A (en) 1972-04-11
GB1259387A (ro) 1972-01-05
OA03604A (fr) 1971-03-30
BG17466A3 (ro) 1973-11-10
RO57881A (ro) 1974-11-15
IT1035508B (it) 1979-10-20
IL32673A0 (en) 1969-09-25
MY7500079A (en) 1975-12-31
SU409407A3 (ro) 1973-11-30
DE1938108C3 (de) 1974-01-03
NO129183B (ro) 1974-03-11
BR6911321D0 (pt) 1973-02-13
NL162837B (nl) 1980-02-15
IE33246B1 (en) 1974-05-01
SE363735B (ro) 1974-02-04
IE33246L (en) 1970-02-05
FI50058B (ro) 1975-09-01
NL162837C (nl) 1980-07-15
CY790A (en) 1976-06-01
BE737053A (ro) 1970-02-04
PL88871B1 (ro) 1976-10-30
US3594474A (en) 1971-07-20
FR2015053A1 (ro) 1970-04-24
IL32673A (en) 1973-11-28

Similar Documents

Publication Publication Date Title
DK130306B (da) Analogifremgangsmåde til fremstilling af S-trialkylphosphinguld-1-thio-β-D-glucopyranosider.
DK136314B (da) Analogifremgangsmåde til fremstilling af benzamidoethylpiperaziner.
DK137167B (da) Fremgangsmåde til fremstilling af et stabilt skumdæmpende middel.
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK133375B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-phenylpyrrolidiner.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK122822B (da) Fremgangsmåde til fremstilling af L-asparaginase.
DK128006B (da) Analogifremgangsmåde til fremstilling af 11-desacetoxy-wortmannin.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK123912B (da) Fremgangsmåde til fremstilling af et granulat, der indeholder et olieagtigt eller flydende, terapeutisk anvendeligt glucofuranosid.
DK138021B (da) Fremgangsmåde til fremstilling af aminopenicilliner.
DK128737B (da) Analogifremgangsmåde til fremstilling af 6α-methyl-17α-caproyloxy-19-norprogesteron.
DK140726B (da) Fremgangsmåde til fremstilling af delta2-cephalosporin-forbindelser.
DK123488B (da) Fremgangsmåde til fremstilling af L-asparaginase.
DK122456B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd.
DK122127B (da) Analogifremgangsmåde til fremstilling af 3-phenyl-4-acyloxycarbostyriler.
DK123816B (da) Analogifremgangsmåde til fremstilling af N-phenacylcarbamater.
DK124686B (da) Analogifremgangsmåde til fremstilling af bis-thiachromonylforbindelser.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK128942B (da) Fremgangsmåde til fremstilling af L-asparaginase.
DK131291B (da) Fremgangsmåde til fremstilling af hexaorganoditinforbindelser.

Legal Events

Date Code Title Description
PBP Patent lapsed